Generation of replication-proficient influenza virus NS1 point mutants with interferon-hyperinducer phenotype.

PLoS One

Department of Molecular and Cellular Biology, Centro Nacional de Biotecnología (CSIC), Madrid, Spain; Ciber de Enfermedades Respiratorias (ISCIII), Madrid, Spain.

Published: January 2015

The NS1 protein of influenza A viruses is the dedicated viral interferon (IFN)-antagonist. Viruses lacking NS1 protein expression cannot multiply in normal cells but are viable in cells deficient in their ability to produce or respond to IFN. Here we report an unbiased mutagenesis approach to identify positions in the influenza A NS1 protein that modulate the IFN response upon infection. A random library of virus ribonucleoproteins containing circa 40 000 point mutants in NS1 were transferred to infectious virus and amplified in MDCK cells unable to respond to interferon. Viruses that activated the interferon (IFN) response were subsequently selected by their ability to induce expression of green-fluorescent protein (GFP) following infection of A549 cells bearing an IFN promoter-dependent GFP gene. Using this approach we isolated individual mutant viruses that replicate to high titers in IFN-compromised cells but, compared to wild type viruses, induced higher levels of IFN in IFN-competent cells and had a reduced capacity to counteract exogenous IFN. Most of these viruses contained not previously reported NS1 mutations within either the RNA-binding domain, the effector domain or the linker region between them. These results indicate that subtle alterations in NS1 can reduce its effectiveness as an IFN antagonist without affecting the intrinsic capacity of the virus to multiply. The general approach reported here may facilitate the generation of replication-proficient, IFN-inducing virus mutants, that potentially could be developed as attenuated vaccines against a variety of viruses.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4041880PMC
http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0098668PLOS

Publication Analysis

Top Keywords

ns1 protein
12
generation replication-proficient
8
point mutants
8
ifn response
8
ns1
7
viruses
7
ifn
7
cells
6
virus
5
replication-proficient influenza
4

Similar Publications

Japanese encephalitis virus (JEV), a neuroinvasive and neurovirulent orthoflavivirus, can be prevented in humans with the SA14-14-2 vaccine, a live-attenuated version derived from the wild-type SA14 strain. To determine the viral factors responsible for the differences in pathogenicity between SA14 and SA14-14-2, we initially established a reverse genetics system that includes a pair of full-length infectious cDNAs for both strains. Using this cDNA pair, we then systematically exchanged genomic regions between SA14 and SA14-14-2 to generate 20 chimeric viruses and evaluated their replication capability in cell culture and their pathogenic potential in mice.

View Article and Find Full Text PDF

The Zika virus (ZIKV) epidemic elicited a rapid commitment to the development of animal models for ZIKV research. Non-human primates (NHPs) and mice have made significant contributions to this research, but NHPs are expensive, have a long gestation period, and are available only in small numbers; non-genetically modified mice are resistant to infection. To address these deficiencies, we have established the laboratory opossum, , as a small animal model that complements the mouse and monkey models.

View Article and Find Full Text PDF

E2 Ubiquitin-Conjugating Enzymes Regulates Dengue Virus-2 Replication in .

Microorganisms

December 2024

Program in Public Health, School of Medicine, University of California, Irvine, CA 92617, USA.

, a major vector of dengue virus (DENV), has a global distribution. Identifying the key components of the ubiquitin system of essential for the replication of viruses could help identify targets for developing broad-spectrum antiviral strategies. This study explores the interaction between E2 ubiquitin-conjugating enzymes (Ubc9) and DENV-2 proteins (NS1, NS5, and E) using cell culture and mosquito models.

View Article and Find Full Text PDF
Article Synopsis
  • This study addresses the difficulty of distinguishing dengue fever (DF) from other viral infections by exploring the diagnostic potential of hematological parameters, particularly mean monocyte volume (MMV), in Malaysia.
  • A cross-sectional study analyzed 162 patients with suspected DF, confirming diagnoses through specialized blood tests and measuring various blood parameters using advanced hematology analyzers.
  • Results indicated significant differences in certain blood counts between DF and non-DF patients, with monocyte percentage showing promise as a moderate predictor for DF, although MMV did not correlate, suggesting areas for future research.
View Article and Find Full Text PDF
Article Synopsis
  • Dengue virus (DENV) is a significant global health issue, with severe cases potentially worsened by antibodies that can enhance infection rather than neutralize it.
  • Researchers are exploring the possibility of targeting DENV-infected cells for immune clearance to avoid antibody-dependent enhancement (ADE).
  • This study found that DENV structural proteins are present on infected cell surfaces and can be recognized by immune antibodies, which may facilitate the clearance of infected cells without enriching viral material in certain immune cells.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!